Research
Tracing genetic risk of neurodegenerative disease through variants affecting microglial function
Nature ·
The Brief
- Researchers pooled differentiation of 261 human induced pluripotent stem cell lines into microglia-like cells to study disease genetics.
- The work combined single-cell transcriptomics, cellular phenotyping and CRISPR screening to trace genetic risk variants affecting microglial function.
- The study was published in Nature Genetics on 19 November 2026.
Why it matters
It links genetic risk variants for neurodegenerative disease to the function of microglia, the brain's immune cells, using a large panel of human stem-cell-derived lines, which may help prioritise variants for follow-up work.
Who’s affected
- neuroscientists studying neurodegenerative disease
- geneticists working on risk variant interpretation
- #microglia
- #neurodegeneration
- #genetic risk
- #crispr screening
- #induced pluripotent stem cells
Nature Genetics, Published online: 19 November 2026; doi:10.1038/s41588-026-02839-w We combined pooled differentiation of 261 human induced pluripotent stem cell lines into microglia-like cells with single-cell transcriptomics, cellular phenotyping and CRISPR screening to trace…